The Robert L. Noble Prize (not to be confused with the Nobel Prize) is awarded each year by the Canadian Cancer Society to researchers whose contributions have led to a significant advance in cancer research. The prize consists of 2,000 Canadian dollars for the researcher receiving the prize, and an additional 20,000 Canadian dollars to further his/her cancer research.[1]
It honours Robert L. Noble, a Canadian researcher who in the 1950s helped with the discovery of vincristine and vinblastine, widely used anti-cancer drugs.
Recipients
Source: Canadian Cancer Society
- 2023 – Sheila Singh,[2] Peter Dirks[3]
- 2022 – Samuel Aparicio
- 2021 – Michael Taylor
- 2020 – Nada Jabado
- 2019 – Jerry Pelletier
- 2018 – Pamela Ohashi
- 2017 – Morag Park
- 2016 – Poul Sorensen
- 2014 – Rama Khokha and James T. Rutka
- 2013 – Shoukat Dedhar
- 2012 – Michel Tremblay
- 2011 – John Bell
- 2010 – Mitsu Ikura
- 2009 – Brian Wilson
- 2008 – Mark Henkelman
- 2007 – Dick Hill
- 2006 – Carol Cass
- 2005 – Susan Cole and Roger Deeley
- 2004 – Robert Kerbel
- 2003 – Connie Eaves
- 2002 – Nahum Sonenberg
- 2001 – Chris Bleackley
- 2000 – John Dick
- 1999 – Janet Rossant
- 1998 – Frank L. Graham
- 1997 – Alan Bernstein
- 1996 – Tak Wah Mak
- 1995 – Anthony J. Pawson
- 1994 – Victor Ling
See also
References
- ^ "Robert L. Noble Prize". Canadian Cancer Society. Retrieved 11 January 2015.
- ^ Kutasi, Paul (2024-09-04). "Professor Sheila Singh awarded the Canadian Cancer Society Robert L. Noble Prize - Centre for Discovery in Cancer Research". Centre for Discovery in Cancer Research. Archived from the original on 2024-09-18. Retrieved 2025-02-04.
- ^ "Dr. Peter Dirks Co-recipient of the 2023 Canadian Cancer Society Robert L. Noble Prize". moleculargenetics.utoronto.ca. Retrieved 2025-02-04.